Emergence and Global Dissemination of Host-Specific Streptococcus agalactiae Clones
暂无分享,去创建一个
[1] Simone Aymanns,et al. Human Serum Induces Streptococcal C5a Peptidase Expression , 2009, Infection and Immunity.
[2] I. Margarit,et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. , 2009, The Journal of infectious diseases.
[3] P. Glaser,et al. Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae , 2008, Proceedings of the National Academy of Sciences.
[4] F. Kong,et al. Use of Phenotypic and Molecular Serotype Identification Methods To Characterize Previously Nonserotypeable Group B Streptococci , 2008, Journal of Clinical Microbiology.
[5] D. Dunn,et al. Population Structure of Invasive and Colonizing Strains of Streptococcus agalactiae from Neonates of Six U.S. Academic Centers from 1995 to 1999 , 2008, Journal of Clinical Microbiology.
[6] M. Nei,et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.
[7] R. Rappuoli,et al. Group B Streptococcus: global incidence and vaccine development , 2006, Nature Reviews Microbiology.
[8] J. R. Hull,et al. High-Affinity Interaction between Fibronectin and the Group B Streptococcal C5a Peptidase Is Unaffected by a Naturally Occurring Four-Amino-Acid Deletion That Eliminates Peptidase Activity , 2006, Infection and Immunity.
[9] I. Margarit,et al. Identification of novel genomic islands coding for antigenic pilus‐like structures in Streptococcus agalactiae , 2006, Molecular microbiology.
[10] C. Buchrieser,et al. Genomic diversity and evolution within the species Streptococcus agalactiae. , 2006, Microbes and infection.
[11] B. Spratt,et al. Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] J. Troendle,et al. Phylogenetic Lineages of Invasive and Colonizing Strains of Serotype III Group B Streptococci from Neonates: a Multicenter Prospective Study , 2006, Journal of Clinical Microbiology.
[13] D. Huson,et al. Application of phylogenetic networks in evolutionary studies. , 2006, Molecular biology and evolution.
[14] Jaideep P. Sundaram,et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. Bruant,et al. Acquisition of Insertion Sequences and the GBSi1 Intron by Streptococcus agalactiae Isolates Correlates with the Evolution of the Species , 2005, Journal of bacteriology.
[16] B. Spratt,et al. Multilocus Sequence Typing of Swedish Invasive Group B Streptococcus Isolates Indicates a Neonatally Associated Genetic Lineage and Capsule Switching , 2005, Journal of Clinical Microbiology.
[17] R. Rappuoli,et al. Genome Analysis Reveals Pili in Group B Streptococcus , 2005, Science.
[18] Gustavo Glusman,et al. Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides , 2005, Infection and Immunity.
[19] M. Wiedmann,et al. Molecular Subtyping and Characterization of Bovine and Human Streptococcus agalactiae Isolates , 2005, Journal of Clinical Microbiology.
[20] G. Lindahl,et al. Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens , 2005, Clinical Microbiology Reviews.
[21] M. Gottschalk,et al. Serotype III Streptococcus agalactiae from Bovine Milk and Human Neonatal Infections1 , 2004, Emerging infectious diseases.
[22] T. Peto,et al. Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor , 2004, Journal of Clinical Microbiology.
[23] H. Davies,et al. Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. , 2004, The Journal of infectious diseases.
[24] A. Adriaanse,et al. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe , 2004, The Pediatric infectious disease journal.
[25] N. Uldbjerg,et al. Dynamics of Streptococcus agalactiae Colonization in Women during and after Pregnancy and in Their Infants , 2004, Journal of Clinical Microbiology.
[26] C. Lämmler,et al. Determination of epidemiological relationships of Streptococcus agalactiae isolated from bovine mastitis. , 2003, FEMS microbiology letters.
[27] Philippe Glaser,et al. Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.
[28] W. Melchers,et al. Genetic analysis of Streptococcus agalactiae strains isolated from neonates and their mothers. , 2003, FEMS immunology and medical microbiology.
[29] M. Stronati,et al. [Streptococcus agalactiae]. , 2003, La Pediatria medica e chirurgica : Medical and surgical pediatrics.
[30] Carmen Buchrieser,et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease , 2002, Molecular microbiology.
[31] Ian T. Paulsen,et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. Lindahl,et al. Streptococcal β Protein Has Separate Binding Sites for Human Factor H and IgA-Fc* , 2002, The Journal of Biological Chemistry.
[33] F. Kong,et al. Serotype Identification of Group B Streptococci by PCR and Sequencing , 2002, Journal of Clinical Microbiology.
[34] B. Spellerberg,et al. Horizontal gene transfer and host specificity of beta‐haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb , 2001, Molecular microbiology.
[35] F. Michel,et al. Mutually Exclusive Distribution of IS1548 and GBSi1, an Active Group II Intron Identified in Human Isolates of Group B Streptococci , 2001, Journal of bacteriology.
[36] E. Feil,et al. Population structure and evolutionary dynamics of pathogenic bacteria , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[37] J. Hedegaard,et al. Investigation of the translation-initiation factor IF2 gene, infB, as a tool to study the population structure of Streptococcus agalactiae. , 2000, Microbiology.
[38] J. Harel,et al. Characterization of Streptococcus agalactiae Isolates of Bovine and Human Origin by Randomly Amplified Polymorphic DNA Analysis , 2000, Journal of Clinical Microbiology.
[39] D. Haburchak,et al. Topley and Wilson's Microbiology and Microbial Infections , 1999 .
[40] A. Schuchat. Group B streptococcus , 1999, The Lancet.
[41] A. Schuchat. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.
[42] M. Sellin,et al. Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. , 1998, The Journal of infectious diseases.
[43] P. Berche,et al. Molecular characterization and expression analysis of the superoxide dismutase gene from Streptococcus agalactiae. , 1997, Gene.
[44] G. Keefe,et al. Streptococcus agalactiae mastitis: a review. , 1997, The Canadian veterinary journal = La revue veterinaire canadienne.
[45] N. E. Jensen,et al. Epidemiological aspects of group B streptococci of bovine and human origin , 1996, Epidemiology and Infection.
[46] P. Ferrieri,et al. Conservation of the C5a peptidase genes in group A and B streptococci , 1996, Infection and immunity.
[47] M. Kilian,et al. Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease , 1996, Infection and immunity.
[48] A. Podbielski,et al. Similarity between the group B and A streptococcal C5a peptidase genes , 1992, Infection and immunity.
[49] P. G. Jerlström,et al. The IgA‐binding β antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions , 1991, Molecular microbiology.
[50] K. Timmis,et al. The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. , 1991, Molecular microbiology.
[51] J. Elliott,et al. Whole-cell protein patterns of nonhemolytic group B, type Ib, streptococci isolated from humans, mice, cattle, frogs, and fish , 1990, Journal of clinical microbiology.
[52] M. T. Parker,et al. Streptococcus and Lactobacillus. , 1990 .
[53] J. Musser,et al. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[54] P. Ross. Occasional Review: Group-B Streptococcus—Profile of an Organism* , 1984 .
[55] P. Ross. Group-B streptococcus--profile of an organism. , 1984, Journal of medical microbiology.
[56] D. Okada,et al. The emergence of group B streptococci in infections of the newborn infant. , 1977, Annual review of medicine.
[57] R. F. Smith,et al. Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. , 1968, Applied microbiology.